BC
Bruce & Co Portfolio holdings
AUM
$308M
1-Year Return
16.62%
This Quarter Return
+9.8%
1 Year Return
+16.62%
3 Year Return
+23.4%
5 Year Return
+75.93%
10 Year Return
+183.38%
AUM
$388M
AUM Growth
+$24M
(+6.6%)
Cap. Flow
-$41.1M
Cap. Flow
% of AUM
-10.6%
Top 10 Holdings %
Top 10 Hldgs %
73.22%
Holding
38
New
4
Increased
1
Reduced
11
Closed
1
Top Buys
| 1 |
U-Haul Holding Co Series N
UHAL.B
|
$36.3M |
| 2 |
AT&T
T
|
$1.1M |
| 3 |
908 Devices
MASS
|
$520K |
| 4 |
LAVA Therapeutics
LVTX
|
$350K |
| 5 |
Personalis
PSNL
|
$99K |
Top Sells
| 1 |
U-Haul Holding Co
UHAL
|
$40.9M |
| 2 |
Allstate
ALL
|
$6.92M |
| 3 |
AbbVie
ABBV
|
$3.39M |
| 4 |
Merck
MRK
|
$2.33M |
| 5 |
Ashland
ASH
|
$1.08M |
Sector Composition
| 1 | Healthcare | 35.56% |
| 2 | Utilities | 30.33% |
| 3 | Industrials | 12.47% |
| 4 | Communication Services | 6.4% |
| 5 | Financials | 6.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Organon & Co
OGN
$2.52B
| $879K | 0.23% |
31,470
-500
| -2% | -$14K |
|
27
Viatris
VTRS
$12B
| $671K | 0.17% |
60,272
-1,240
| -2% | -$13.8K |
|
28
Fate Therapeutics
FATE
$112M
| $575K | 0.15% |
57,000
| – | – |
|
|
29
908 Devices
MASS
$198M
| $520K | 0.13% |
+68,286
| New | +$520K |
|
|
30
LAVA Therapeutics
LVTX
$40.8M
| $350K | 0.09% |
+100,000
| New | +$350K |
|
31
RLI Corp
RLI
$6.22B
| $315K | 0.08% |
4,800
| – | – |
|
32
Warner Bros
WBD
$29.1B
| $138K | 0.04% |
14,510
-108,048
| -88% | -$1.02M |
|
|
33
Personalis
PSNL
$451M
| $99K | 0.03% |
+50,000
| New | +$99K |
|
34
GE Aerospace
GE
$299B
| – | – |
-16,051
| Closed | -$619K |
|